Biohorizons Camlog joins Henry Schein’s Practice Pink program to continue supporting the campaign against cancer in 2023

Flyer Practice Pink - Biohorizons Camlog

Practice Pink has raised more than $1.9 million in 17 years to help support programs for cancer patients and their families

MELVILLE, N.Y. (EE.UU.) / Madrid (Spain), October 10, 2023 – Henry Schein, Inc. (Nasdaq: HSIC) today announced the annual launch of its Practice Pink® program, an initiative that has raised more than $1.9 million over the past 17 years to support nonprofit organizations dedicated to to cancer research and prevention. BioHorizons Camlog, as part of Henry Schein’s Oral Reconstruction Group, also joins this program.

Practice Pink is a global initiative of Henry Schein Cares, the company’s global corporate social responsibility program. Through Practice Pink, Henry Schein, together with non-governmental organizations and provider partners in North America and Europe, is helping dental and medical health professionals raise awareness and support the cure of breast cancer and other cancers.

By offering customers a variety of pink products, including healthcare consumables, clinic supplies and apparel, Practice Pink supports important cancer research and prevention efforts.

As part of the company’s participation in the Practice Pink program, Henry Schein Medical and the dental division of Henry Schein in Spain donate a portion of the sales of these pink products to the Aladina Foundation during the month of October, to support This non-profit organization’s research, prevention efforts and early detection of the disease, in addition to helping improve access to medical care. BioHorizons Camlog, one of the leading suppliers of oral reconstruction products and part of Henry Schein, Inc., will also contribute by including its biomaterials in Practice Pink’s offering in Spain.

Aladina each year provides comprehensive help to more than 1,500 children and adolescents, cancer patients and their families. Aladina supports and cares for families throughout the illness, especially in the worst moments, offers a complete program of free psychological care for sick children and their families, inside and outside hospitals, carries out important reforms and improvements in hospitals public, to make the stay more bearable and covers expenses derived from the illness for families with fewer resources, among other programs such as volunteering, scholarships and palliative care. *)

The Practice Pink program supports U.S. organizations such as the American Cancer Society, Northwell Health Cohen Children’s Medical Center, and Stony Brook Children’s Hospital. The program also supports several organizations around the world, such as Cancer Research UK (United Kingdom), KiKa (Netherlands), LILT (Italy) and Odyssea (France), among others.

“At Henry Schein, we believe strongly in the potential of public-private partnerships to contribute to a healthier world, and the Henry Schein Cares Practice Pink program exemplifies this belief,” said Maureen Knott, Vice President U.S. Supplier Initiatives, Henry Schein and President, Henry Schein Cares Foundation. “Thanks to the combined dedication and generosity of our supplier and customer partners, we will continue our commitment to advancing cancer research and prevention, all while fighting together for a world where cancer is no longer a threat.”

*) Source: www.aladina.org

 About Henry Schein Cares

Henry Schein Cares is built on five pillars: empowering the Schein team to reach their full potential, advancing health equity and expanding access to care for underserved communities, accelerating environmental sustainability, and strengthening and diversifying our supply chain. and maintain solid ethical management. The health care activities supported by Henry Schein Cares focus on four main areas: (1) wellness, treatment, prevention and education; (2) capacity development; (3) emergency or disaster preparedness and response; and (4) strengthening the health system.

Rooted in a deep commitment to social responsibility and the philosophy of informed self-interest championed by Benjamin Franklin, Henry Schein Cares’ purpose-driven vision is to “do good by doing well.” Our commitment to sustained, long-term financial success while creating shared value for society is achieved through the work of Henry Schein Cares and our stakeholder model based on the five components of our mosaic of success. For more information about how we are making a difference, visit: www.henryschein.com/corporatecitizenship.

About BioHorizons Camlog

BioHorizons and Camlog are leading providers of premium dental implant systems, rehabilitation components, a full line of biologics and digital solutions. They are committed to developing evidence-based and scientifically proven products, as well as offering continuing education according to the highest standards.

With headquarters in the US and Europe respectively, BioHorizons and Camlog’s geographic positions allow them to efficiently serve direct subsidiaries in the Americas and Western Europe, as well as their entire distribution network in more than 90 countries around the world. world.

BioHorizons and Camlog are part of Henry Schein, Inc., a healthcare professional solutions company powered by a network of people and technology. With more than 23,000 Schein team members worldwide, the company’s network of trusted advisors provides more than 1 million clients globally with more than 300 value-added solutions that help improve operational success and clinical results. Business, clinical and supply chain solutions help medical and dental clinics work more efficiently so they can deliver quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, and other healthcare facilities.

CONTACT:

Stefanie Fleige
Director, Corporate Media Relations EMEA, Henry Schein
Email: Stefanie.Fleige@henryschein.de
+49 40 65668 691

Barbara Malo de Molina
Marketing & Education Manager, BioHorizons Camlog Ibérica
bmalodemolina@biohorizons.com
+34 628 781 550

Comments

REGISTRY

Please accept the Terms and Conditions to proceed.

Login